Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Free Cash Flow (2016 - 2025)

Nephros (NEPH) has 16 years of Free Cash Flow data on record, last reported at $99000.0 in Q3 2025.

  • For Q3 2025, Free Cash Flow rose 115.89% year-over-year to $99000.0; the TTM value through Sep 2025 reached $2.7 million, up 231.03%, while the annual FY2024 figure was -$555000.0, 173.8% down from the prior year.
  • Free Cash Flow reached $99000.0 in Q3 2025 per NEPH's latest filing, down from $994000.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $1.3 million in Q4 2024 and bottomed at -$1.8 million in Q1 2022.
  • Average Free Cash Flow over 5 years is -$162210.5, with a median of -$170000.0 recorded in 2022.
  • Peak YoY movement for Free Cash Flow: tumbled 2247.44% in 2022, then surged 574.73% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$335000.0 in 2021, then skyrocketed by 41.79% to -$195000.0 in 2022, then plummeted by 40.0% to -$273000.0 in 2023, then soared by 574.73% to $1.3 million in 2024, then tumbled by 92.36% to $99000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $99000.0 in Q3 2025, $994000.0 in Q2 2025, and $322000.0 in Q1 2025.